Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment
19. April 2021 08:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, April 19, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
23. März 2021 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, March 23, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
11. März 2021 09:00 ET
|
Sunshine Biopharma Inc.
MONTREAL, March 11, 2021 (GLOBE NEWSWIRE) -- Sunshine Biopharma Inc. (OTC PINK: “SBFM”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral...